A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer
Clinical trial NCT03197935 · COMPLETED
Trial details
- NCT number
- NCT03197935
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-24
- Primary completion
- 2020-04-03
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.